These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma. Young RJ, Urban D, Angel C, Corry J, Lyons B, Vallance N, Kleid S, Iseli TA, Solomon B, Rischin D. Br J Cancer; 2015 Mar 17; 112(6):1098-104. PubMed ID: 25688737 [Abstract] [Full Text] [Related]
7. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma. Wong KS, Krane JF, Jo VY. Cancer Cytopathol; 2019 Oct 17; 127(10):632-642. PubMed ID: 31509355 [Abstract] [Full Text] [Related]
8. pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer. Dreyer JH, Hauck F, Barros MHM, Niedobitek G. Appl Immunohistochem Mol Morphol; 2017 Oct 17; 25(5):366-373. PubMed ID: 26657876 [Abstract] [Full Text] [Related]
9. Fine-needle aspiration of cervical lymph nodes yields adequate materials for accurate HPV testing in metastatic head and neck squamous cell carcinomas. Hou Y, Chaudhary S, Shen R, Li Z. Diagn Cytopathol; 2016 Oct 17; 44(10):792-8. PubMed ID: 27465660 [Abstract] [Full Text] [Related]
10. HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Lohaus F, Linge A, Tinhofer I, Budach V, Gkika E, Stuschke M, Balermpas P, Rödel C, Avlar M, Grosu AL, Abdollahi A, Debus J, Bayer C, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, von Neubeck C, Baretton GB, Löck S, Thames HD, Krause M, Baumann M, DKTK-ROG. Radiother Oncol; 2014 Dec 17; 113(3):317-23. PubMed ID: 25480095 [Abstract] [Full Text] [Related]
11. The utility of p16 immunostaining in fine needle aspiration in p16-positive head and neck squamous cell carcinoma. Xu B, Ghossein R, Lane J, Lin O, Katabi N. Hum Pathol; 2016 Aug 17; 54():193-200. PubMed ID: 27105759 [Abstract] [Full Text] [Related]
12. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Begum S, Gillison ML, Nicol TL, Westra WH. Clin Cancer Res; 2007 Feb 15; 13(4):1186-91. PubMed ID: 17317828 [Abstract] [Full Text] [Related]
13. Potential impact of human papilloma virus on survival of basaloid squamous carcinoma of the head and neck. Jacobi C, Ayx I, Fritsche K, Piontek G, Hoffmann D, Weirich G, Knopf A. Oncotarget; 2015 Feb 20; 6(5):3462-70. PubMed ID: 25739121 [Abstract] [Full Text] [Related]
14. The Fidelity of p16 Staining as a Surrogate Marker of Human Papillomavirus Status in Fine-Needle Aspirates and Core Biopsies of Neck Node Metastases: Implications for HPV Testing Protocols. Holmes BJ, Maleki Z, Westra WH. Acta Cytol; 2015 Feb 20; 59(1):97-103. PubMed ID: 25765380 [Abstract] [Full Text] [Related]
15. p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region. Prigge ES, Toth C, Dyckhoff G, Wagner S, Müller F, Wittekindt C, Freier K, Plinkert P, Hoffmann J, Vinokurova S, Klussmann JP, von Knebel Doeberitz M, Reuschenbach M. Int J Cancer; 2015 Apr 01; 136(7):1589-99. PubMed ID: 25104331 [Abstract] [Full Text] [Related]
16. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab. Rosenthal DI, Harari PM, Giralt J, Bell D, Raben D, Liu J, Schulten J, Ang KK, Bonner JA. J Clin Oncol; 2016 Apr 20; 34(12):1300-8. PubMed ID: 26712222 [Abstract] [Full Text] [Related]
17. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma. Hajek M, Sewell A, Kaech S, Burtness B, Yarbrough WG, Issaeva N. Cancer; 2017 May 15; 123(10):1778-1790. PubMed ID: 28295222 [Abstract] [Full Text] [Related]
18. HPV-positive head and neck tumours, a distinct clinical entity. Nevens D, Nuyts S. B-ENT; 2015 May 15; 11(2):81-7. PubMed ID: 26563006 [Abstract] [Full Text] [Related]
19. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Hafkamp HC, Speel EJ, Haesevoets A, Bot FJ, Dinjens WN, Ramaekers FC, Hopman AH, Manni JJ. Int J Cancer; 2003 Nov 10; 107(3):394-400. PubMed ID: 14506739 [Abstract] [Full Text] [Related]
20. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang MB, Srivatsan ES. Laryngoscope; 2002 Mar 10; 112(3):472-81. PubMed ID: 12148857 [Abstract] [Full Text] [Related] Page: [Next] [New Search]